The Effectiveness of Darbepoetin Alfa Administered Every 3 Weeks on Hematologic Outcomes and Quality of Life in Older Patients With Chemotherapy-Induced Anemia
Author:
Affiliation:
1. a Georgetown University/Center for Cancer and Blood Disorders, Bethesda, Maryland, USA
2. b Amgen Inc., Thousand Oaks, California, USA
3. c H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-5-584
Reference29 articles.
1. Chemotherapy-induced anemia in adults: Incidence and treatment;Groopman;J Natl Cancer Inst,1999
2. Factors influencing quality of life in cancer patients: Anemia and fatigue;Cella;Semin Oncol,1998
3. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition;Vogelzang;Semin Hematol,1997
4. Impact of fatigue on quality of life in oncology patients;Curt;Semin Hematol,2000
5. Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition;Curt;The Oncologist,2000
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Replica a la carta al editor titulada: «Efectividad y seguridad de la eritropoyetina alfa en el paciente (ortopédico) mayor de 65 años»;Revista Española de Geriatría y Gerontología;2019-07
2. Efectividad y seguridad de la eritropoyetina alfa en el paciente (ortopédico) mayor de 65 años;Revista Española de Geriatría y Gerontología;2019-03
3. Association of anemia with health-related quality of life and survival: a large population-based cohort study;Haematologica;2018-10-11
4. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model;Health Technology Assessment;2016-02
5. Darbepoetin Alfa Administered Once Every Three Weeks for the Treatment of Anemia in Elderly Patients with Non-myeloid Tumors Receiving Chemotherapy;Tumori Journal;2014-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3